PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Rupatadine fumarate - Allergic rhinitis
PAD Profile : Rupatadine fumarate - Allergic rhinitis
Keywords :
Hay fever, hayfever, antihistamines, allergy, seasonal allergic rhinitis, pollen allergy, non-sedating antihistamines
Brand Names Include :
Rupafin
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Cetirizine hydrochloride
- Loratadine
- Desloratadine
- Levocetirizine
- Bilastine
- Mizolastine
- Acrivastine
- Fexofenadine hydrochloride
- House dust mites allergen extract
- White Birch pollen allergen extract
- Chlorphenamine maleate
- Ketotifen fumarate
- Promethazine hydrochloride
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Rupatadine tablets for allergic rhinitis have not been recommended for use within the local guidelines.
Rupatadine is considerably more expensive and is not considered a cost-effective treatment option.
Associated BNF Codes
03. Respiratory System
03.04.01. Antihistamines